These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 17911366

  • 1. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M, Murphy CF, Meyers BS.
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [Abstract] [Full Text] [Related]

  • 2. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.
    Zimmerman M, Posternak MA, Chelminski I.
    J Psychiatr Res; 2004 Oct; 38(6):577-82. PubMed ID: 15458853
    [Abstract] [Full Text] [Related]

  • 3. Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores.
    Ruhé HG, Dekker JJ, Peen J, Holman R, de Jonghe F.
    Compr Psychiatry; 2005 Oct; 46(6):417-27. PubMed ID: 16275208
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
    Pae CU, Mandelli L, Kim TS, Han C, Masand PS, Marks DM, Patkar AA, Steffens DC, De Ronchi D, Serretti A.
    Biomed Pharmacother; 2009 Mar; 63(3):228-35. PubMed ID: 18502089
    [Abstract] [Full Text] [Related]

  • 5. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
    Soares CN, Kornstein SG, Thase ME, Jiang Q, Guico-Pabia CJ.
    J Clin Psychiatry; 2009 Oct; 70(10):1365-71. PubMed ID: 19906341
    [Abstract] [Full Text] [Related]

  • 6. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 8. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L, Pitrosky B, Padmanabhan SK, Germain JM, Tourian KA.
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [Abstract] [Full Text] [Related]

  • 10. Inter-rater reliability of the Hamilton Depression Rating Scale as a diagnostic and outcome measure of depression in primary care.
    Morriss R, Leese M, Chatwin J, Baldwin D, THREAD Study Group.
    J Affect Disord; 2008 Dec; 111(2-3):204-13. PubMed ID: 18374987
    [Abstract] [Full Text] [Related]

  • 11. Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.
    Feighner JP, Sverdlov L, Hlavka J, Nicolau G, Cartwright K, Freed JS.
    Int Clin Psychopharmacol; 2008 Jan; 23(1):29-35. PubMed ID: 18090505
    [Abstract] [Full Text] [Related]

  • 12. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment.
    Pope HG, Amiaz R, Brennan BP, Orr G, Weiser M, Kelly JF, Kanayama G, Siegel A, Hudson JI, Seidman SN.
    J Clin Psychopharmacol; 2010 Apr; 30(2):126-34. PubMed ID: 20520285
    [Abstract] [Full Text] [Related]

  • 13. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
    Pae CU, Mandelli L, Han C, Ham BJ, Masand PS, Patkar AA, Steffens DC, De Ronchi D, Serretti A.
    Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
    [Abstract] [Full Text] [Related]

  • 14. An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder.
    Hooper CL, Bakish D.
    J Psychiatry Neurosci; 2000 Mar; 25(2):178-84. PubMed ID: 10740991
    [Abstract] [Full Text] [Related]

  • 15. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL, Evans KR, Sills TL, Kalali AH.
    Depress Anxiety; 2008 Mar; 25(12):1006-13. PubMed ID: 18800370
    [Abstract] [Full Text] [Related]

  • 16. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A, Alonso A, Molenberghs G, Vangeneugden T, Mallinckrodt CH.
    J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
    [Abstract] [Full Text] [Related]

  • 17. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI, McFall JP.
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [Abstract] [Full Text] [Related]

  • 18. Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.
    Robinson DS, Gilmor ML, Yang Y, Moonsammy G, Azzaro AJ, Oren DA, Campbell BJ.
    Psychopharmacol Bull; 2007 Nov; 40(3):15-28. PubMed ID: 18007565
    [Abstract] [Full Text] [Related]

  • 19. Can people with nonsevere major depression benefit from antidepressant medication?
    Stewart JA, Deliyannides DA, Hellerstein DJ, McGrath PJ, Stewart JW.
    J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
    [Abstract] [Full Text] [Related]

  • 20. White matter hyperintensity progression and late-life depression outcomes.
    Taylor WD, Steffens DC, MacFall JR, McQuoid DR, Payne ME, Provenzale JM, Krishnan KR.
    Arch Gen Psychiatry; 2003 Nov; 60(11):1090-6. PubMed ID: 14609884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.